{"id":751521,"date":"2022-01-15T19:44:24","date_gmt":"2022-01-15T19:44:24","guid":{"rendered":"https:\/\/www.ghanamma.com\/2022\/01\/15\/glaxosmithkline-rejects-68b-offer-from-unilever-for-consumer-goods-division\/"},"modified":"2022-01-15T19:44:24","modified_gmt":"2022-01-15T19:44:24","slug":"glaxosmithkline-rejects-68b-offer-from-unilever-for-consumer-goods-division","status":"publish","type":"post","link":"https:\/\/www.ghanamma.com\/2022\/01\/15\/glaxosmithkline-rejects-68b-offer-from-unilever-for-consumer-goods-division\/","title":{"rendered":"GlaxoSmithKline rejects $68B offer from Unilever for consumer goods division"},"content":{"rendered":"<p><\/p>\n<div>\n<div class=\"slide-image-container\">\n    <img loading=\"lazy\" decoding=\"async\" style=\"width: 100%;\" width=\"800\" height=\"535\" src=\"https:\/\/www.ghanamma.com\/wp-content\/uploads\/2022\/01\/GlaxoSmithKline-rejects-68B-offer-from-Unilever-for-consumer-goods-division.jpg\" title=\"GlaxoSmithKline rejects $68B offer from Unilever for consumer goods division\" alt=\"GlaxoSmithKline rejects $68B offer from Unilever for consumer goods division\"\/>\n<\/div>\n<p>A security guard hoists a GlaxoSmithKline company flag outside the GSK factory in Shanghai, China, in 2013. GSK has rejected three unsolicited offers from Unilever, including one worth $68 billion, to acquire its consumer goods division. File Photo by EPA-EFE<\/p>\n<article itemprop=\"articleBody\">\n<p><span class=\"story_dl\">Jan. 15 (UPI) &#8212;<\/span> Healthcare product maker GlaxoSmithKline has rejected three unsolicited offers from Unilever, including one worth $68 billion, to acquire its consumer goods division, the company confirmed Saturday.<\/p>\n<p>If successful, the takeover between the two London-based companies would add GSK brands such as Sensodyne, Aquafresh and ChapStick to the list of brands owned by Unilever &#8212; which include Axe, Dove and Vaseline.\n<\/p>\n<\/article>\n<p>&#8220;GSK rejected all three proposals made on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects,&#8221; the company said in a statement.<\/p>\n<p>The GSK announcement was made in response to reporting from The Sunday Times of London, which did not reveal how it had obtained the information. Unilever has also since released a statement confirming the attempted acquisition in response to the reporting from the Times.\n<\/p>\n<p>&#8220;GSK Consumer Healthcare is a leader in the attractive consumer health space and would be a strong strategic fit as Unilever continues to re-shape its portfolio,&#8221; Unilever said in its statement. &#8220;There can be no certainty that any agreement will be reached.&#8221;<\/p>\n<p>GSK&#8217;s consumer healthcare business is a joint venture with U.S. company Pfizer, which has not released a statement about the attempted acquisition.\n<\/p>\n<p>GSK revealed that the most recent $68 billion offer from Unilever came Dec. 20 and comprised about $57 billion in cash and about $11.4 billion in Unilever shares.\n<\/p>\n<p>&#8220;The board of GSK unanimously concluded that the proposals were not in the best interests of GSK shareholders,&#8221; the company said, noting that its business is well-positioned to grow in the consumer healthcare sector.<\/p>\n<p>GSK said that the company &#8220;remains focused&#8221; on spinning off its Consumer Healthcare business into a new company by mid-2022, after hiring former Tesco CEO Dave Lewis to lead the new venture.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A security guard hoists a GlaxoSmithKline company flag outside the GSK factory in Shanghai, China, in 2013. GSK has rejected three unsolicited offers from Unilever, including one worth $68 billion, to acquire its consumer goods division. File Photo by EPA-EFE Jan. 15 (UPI) &#8212; Healthcare product maker GlaxoSmithKline has rejected three unsolicited offers from Unilever, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":751522,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56],"tags":[],"class_list":["post-751521","post","type-post","status-publish","format-standard","has-post-thumbnail","category-world"],"_links":{"self":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/posts\/751521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/comments?post=751521"}],"version-history":[{"count":0,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/posts\/751521\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/media?parent=751521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/categories?post=751521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ghanamma.com\/2022\/wp-json\/wp\/v2\/tags?post=751521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}